Insight Molecular Diagnostics Inc. IMDX
3.92
(0.03)
(0.76%)
as of 25 Sep
- Market cap
- $129.3M
- P/E
- 0.0×
Follow IMDX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 128.69 | 87.79 | 39.90 | 16.80 | 16.54 | 56.37 |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | (25.47) | (27.31) | (3.96) | (5.71) | (5.81) | (41.22) |
P/B ratio |
— | — | — | — | 4.67 | 2.96 | 1.11 | 1.23 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | 16.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | 123.51 | 74.00 | 21.64 | 12.09 | 33.26 | 53.75 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 3.50 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (5.78) | (4.53) | (0.45) | (0.78) | (3.02) | (9.82) |
EV/FCF |
— | — | — | — | (5.52) | (4.26) | (0.42) | (0.76) | (2.95) | (8.59) |
Quick Ratio |
2.90 | 1.88 | 1.52 | 5.06 | 0.89 | 2.50 | 1.85 | 1.38 | 1.41 | 1.11 |
Current Ratio |
2.97 | 1.91 | 1.55 | 5.17 | 1.03 | 2.77 | 2.11 | 1.49 | 1.62 | 1.27 |
Net Debt/EBITDA |
1.13 | 0.39 | 0.57 | 0.94 | 0.22 | 0.61 | (2.99) | 0.40 | (0.53) | (0.67) |
Debt/Assets |
2.15% | 13.30% | 5.61% | 4.78% | 2.72% | 2.22% | 2.73% | 0.00% | 114.25% | 175.28% |
Debt/Equity |
0.03 | 0.31 | 0.16 | 0.06 | 0.05 | 0.05 | 0.08 | 0.00 | (3.27) | (1.43) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | 0.13 |
Operating CF/Net income |
0.67 | 0.69 | 0.74 | 0.88 | 0.87 | 0.56 | 0.62 | 0.81 | 0.34 | 0.44 |
Capex/Depreciation |
(0.27) | (0.14) | (0.02) | (2.05) | (1.34) | (0.53) | (0.18) | 0.04 | (0.33) | (1.45) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (110.14%) | (271.64%) | (402.61%) | (130.91%) | (93.07%) | (129.88%) | (147.57%) | (104.91%) | (1,480.67%) | 229.65% | |
| (82.18%) | (157.12%) | (159.66%) | (90.84%) | (62.83%) | (59.63%) | (56.55%) | (32.83%) | (110.32%) | (165.10%) | |
ROIC |
0.00% | 0.00% | 0.00% | (135.05%) | (68.34%) | (96.18%) | (67.78%) | (142.35%) | (199.01%) | (2,334.00%) |
Return on Tangible Assets |
(122.60%) | (395.73%) | (426.36%) | (100.82%) | (857.16%) | (209.38%) | (332.20%) | (393.30%) | (753.48%) | (519.57%) |
Average Days of Receivables |
— | — | — | — | 60.93 | 238.63 | 766.58 | 117.54 | 313.00 | 101.53 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 805.92% | 229.07% | 762.11% | 618.36% | 523.07% | 392.11% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 1,914.64% | 1,039.31% | 2,402.19% | 929.94% | 752.15% | 418.64% |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.00 | 0.00 | 0.44 | 0.50 | 0.62 | 0.76 | 0.42 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 416.61% | 311.24% | 1,048.23% | 183.63% | 93.20% | 54.72% |
Graham Net Nets |
— | — | — | — | (0.08) | (0.29) | (1.05) | (1.73) | (1.14) | (0.18) |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 9.64 | 6.13 |
Earnings Yield |
— | — | — | — | (19.25%) | (32.72%) | (189.65%) | (115.28%) | (184.87%) | (21.60%) |
Free Cash Flow Yield |
— | — | — | — | (17.39%) | (19.79%) | (130.56%) | (95.27%) | (68.15%) | (11.10%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.49 | 0.17 | 0.20 | 0.14 | 0.13 |
Operating CF per Share |
(5.67) | (8.87) | (6.16) | (7.69) | (7.94) | (8.08) | (8.23) | (3.05) | (1.58) | (0.73) |
Capex per Share |
(0.08) | (0.06) | (0.02) | (0.36) | (0.37) | (0.51) | (0.78) | 0.01 | (0.04) | (0.10) |
Free Cash Flow per Share |
(5.75) | (8.93) | (6.17) | (8.04) | (8.31) | (8.59) | (9.01) | (3.04) | (1.62) | (0.83) |
Cash per Share |
9.36 | 5.54 | 4.47 | 8.75 | 2.39 | 7.61 | 3.69 | 1.23 | 0.66 | 0.40 |
Shareholders Equity per Share |
7.43 | 2.92 | 1.81 | 12.02 | 10.23 | 14.67 | 6.19 | 2.68 | (0.94) | (1.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.43 | 2.92 | 1.81 | 12.02 | 10.23 | 14.67 | 6.19 | 2.68 | (0.94) | (1.03) |
Free Cash Flow |
(7.63) | (13.48) | (11.68) | (20.63) | (27.21) | (38.19) | (49.91) | (23.25) | (21.20) | (25.37) |
Working Capital |
8.42 | 4.07 | 3.08 | 18.52 | 0.23 | 25.02 | 13.43 | 3.50 | 4.48 | 3.23 |
Capital Expenditures |
(0.11) | (0.09) | (0.03) | (0.92) | (1.23) | (2.25) | (4.34) | 0.07 | (0.51) | (3.18) |
Net Current Asset Value |
8.11 | 2.72 | 2.55 | 13.94 | (12.71) | (55.20) | (40.26) | (43.73) | (35.60) | (41.91) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.02 | 4.53 | (0.05) | 0.27 | 0.79 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | (2,461.51%) | (2,916.15%) | (7,664.09%) | (1,911.04%) | (3,225.04%) | (1,238.52%) |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.56 | 0.81 | 2.08 | 0.12 | 0.28 | 0.76 | 2.76 | 0.44 | 0.44 | 0.34 |
Cash ROIC |
(36.35%) | (100.60%) | (98.74%) | (42.47%) | (68.31%) | (40.47%) | (94.42%) | (90.72%) | (66.56%) | (110.10%) |
Accounts Receivable Turnover |
— | — | — | — | 1.32 | 2.68 | 0.56 | 1.20 | 1.79 | 2.96 |
Accounts Payable Turnover |
1.09 | 1.94 | 3.28 | 1.08 | 4.12 | 0.69 | 0.64 | 0.99 | 0.88 | 0.84 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.20 | 4.11 |
Average Days of Payables |
398.01 | 110.13 | 108.39 | 497.63 | 85.00 | 849.16 | 468.59 | 319.12 | 524.95 | 528.49 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 142.62 | 0.00 | 0.00 | 131.16 | 92.65 |
Average Receivables |
— | — | — | — | 0.92 | 0.82 | 1.72 | 1.25 | 1.05 | 1.37 |
Average Payables |
0.35 | 0.30 | 0.17 | 0.32 | 0.45 | 1.12 | 1.53 | 1.10 | 1.30 | 2.09 |
Average Inventory |
— | — | — | — | — | — | — | — | 0.36 | 0.43 |
Average Assets |
13.59 | 12.33 | 9.87 | 24.69 | 47.64 | 107.49 | 129.83 | 87.49 | 54.99 | 30.42 |
Average Common Equity |
10.14 | 7.13 | 3.91 | 17.13 | 32.16 | 49.35 | 49.75 | 27.38 | 4.10 | (21.87) |
Columns are period end dates